Baxter International

Baxter International EBIT

The EBIT of Baxter International (BAX) as of Nov 4, 2026 is -267.00 M USD. In the previous year, EBIT was 14.00 M USD — a change of -2,007.14% (lower).

EBIT

-267.00 MUSD

YoY

-2,007.14%

Last updated:

In 2025, Baxter International's EBIT was -267.00 M USD, a -2,007.14% increase from the 14.00 M USD EBIT recorded in the previous year.

The Baxter International EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2021
1.35 B USD
Jan 1, 2022
-2.84 B USD
Jan 1, 2023
707.00 M USD
Jan 1, 2024
14.00 M USD
Jan 1, 2025
-267.00 M USD
Jan 1, 2026 (e)
1.55 B USD
Jan 1, 2027 (e)
1.52 B USD
Jan 1, 2028 (e)
1.61 B USD
The Baxter International EBIT history
YEAREBITYoY
est1.61 BUSD+5.60%
est1.52 BUSD-1.48%
est1.55 BUSD-679.43%
-267.00 MUSD-2,007.14%
14.00 MUSD-98.02%
707.00 MUSD-124.94%
-2.84 BUSD-310.00%
1.35 BUSD-16.46%
1.62 BUSD+49.49%
1.08 BUSD-36.78%
1.71 BUSD+32.76%
1.29 BUSD+72.89%
745.00 MUSD+65.92%
449.00 MUSD-31.55%
656.00 MUSD+32.26%
496.00 MUSD-82.42%
2.82 BUSD-4.24%
2.95 BUSD+37.92%
2.14 BUSD-25.76%
2.88 BUSD+12.21%
2.56 BUSD+18.27%
2.17 BUSD+17.76%
1.84 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baxter International Revenue

Baxter International Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
12.15 B USD
1.35 B USD
1.28 B USD
Jan 1, 2022
10.06 B USD
-2.84 B USD
-2.43 B USD
Jan 1, 2023
10.36 B USD
707.00 M USD
2.66 B USD
Jan 1, 2024
10.64 B USD
14.00 M USD
-649.00 M USD
Jan 1, 2025
11.24 B USD
-267.00 M USD
-957.00 M USD
Jan 1, 2026 (e)
11.71 B USD
1.55 B USD
1.07 B USD
Jan 1, 2027 (e)
11.97 B USD
1.52 B USD
1.04 B USD
Jan 1, 2028 (e)
12.24 B USD
1.61 B USD
1.11 B USD

Baxter International Margins

Baxter International stock margins

The Baxter International margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Baxter International. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Baxter International.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
38.86 %
11.11 %
10.57 %
Jan 1, 2022
35.29 %
-28.19 %
-24.19 %
Jan 1, 2023
40.06 %
6.82 %
25.64 %
Jan 1, 2024
37.46 %
0.13 %
-6.10 %
Jan 1, 2025
30.05 %
-2.37 %
-8.51 %
Jan 1, 2026 (e)
30.05 %
13.21 %
9.11 %
Jan 1, 2027 (e)
30.05 %
12.74 %
8.68 %
Jan 1, 2028 (e)
30.05 %
13.15 %
9.03 %

Baxter International Stock analysis

What does Baxter International do? Baxter International Inc is a global company specialized in the development, manufacturing, and marketing of medical therapy products to improve the lives of patients worldwide. It was originally founded in 1931 as the American Hospital Supply Corporation. Since then, the company has continuously evolved and is now a leading provider of medical products and services. The company's history began in 1931 with the founding of the American Hospital Supply Corporation in Illinois. Over the years, the company acquired several small companies and expanded its range of medical products and services. In 1985, the company changed its name to Baxter Travenol Laboratories, Inc. and merged with Travenol Laboratories, Inc. Finally, in 1995, it was renamed Baxter International Inc. to reflect the international focus of the company. Baxter International Inc can be considered as a manufacturer and supplier of medical products in various areas of healthcare. The company is divided into several divisions to better structure and organize its different product and service offerings. The main divisions of the company are infusion systems and devices, parenteral nutrition, renal care products, biopharmaceuticals, and drug delivery systems and bottles. The infusion systems and devices division represents the largest share of Baxter International Inc's revenue. This division is involved in the manufacturing and marketing of products such as infusion pumps and tubing systems, which allow the precise and controlled delivery of fluids and medications into a patient's body. Another important area of Baxter International Inc is the manufacturing of parenteral nutrition. This involves the production of complex nutrient mixtures that are directly injected into the patient's vein when they are unable to receive nutrients in other ways. The company offers a variety of parenteral nutrition solutions enriched with carbohydrates, amino acids, and fats. The renal care products division of Baxter International is specialized in the development and manufacturing of devices and materials necessary for dialysis. Baxter International offers a wide range of dialysis machines and solutions that can be used in the treatment of patients with kidney problems. The company has also developed an extensive range of pediatric devices and solutions to meet the needs of children and adults. The biopharmaceuticals division of Baxter International Inc. focuses on the development and production of innovative medications. The company has a particular focus on the treatment of diseases such as hemophilia and immune disorders. Baxter International Inc. also distributes therapies that can be used to treat various diseases such as cancer or neurological disorders. The drug delivery systems and bottles division is responsible for the manufacturing of accessories, including bottles, bags, and connectors. The company develops and produces a variety of products focusing on drug administration, such as specialized bottles and syringes. Baxter International Inc. offers a wide range of products aimed at improving the health and lives of patients. In addition to infusion pumps and parenteral nutrition, the company also provides wound care devices, blood donation systems, vaccines, and much more. Product development is always tailored to the needs of end-users to ensure the highest possible quality of products and services. In conclusion, Baxter International Inc has established itself as a leading company in the medical and healthcare industry. The expansion of its product range, international focus, and emphasis on meeting the needs of end-users have contributed to the company's continuous growth and success. Furthermore, the company has made a significant contribution to improving healthcare worldwide through its products and services. Baxter International is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Baxter International's EBIT

Baxter International's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Baxter International's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Baxter International's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Baxter International’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Baxter International stock

EBIT of Baxter International is -267.00 M USD in 2025.

EBIT of Baxter International changed from 14.00 M USD to -267.00 M USD, representing a -2,007.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Baxter International since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Baxter International historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Baxter International

All Key Metrics — Baxter International